IL1B and autoinflammatory syndrome: IL-1β is central to the pathogenesis of hereditary autoinflammatory syndromes, and while inhibition is therapeutic, abrupt suppression may disrupt homeostatic immune signaling in genetically predisposed individuals, potentially unmasking or exacerbating underlying genetic susceptibilities [24,31,32].